Position in KALV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$955,550
+$190,186 QoQ
Shares Held
47,469
+0.2% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23.16248499020413.ToString("F0")%
Shared 0.ToString("F0")%
None 76.83751500979587.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. KALV ranks #120 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $955,550 | 47,469 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $765,364 | 47,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $643,079 | 52,798 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $614,720 | 54,376 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $610,673 | 52,918 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $433,291 | 51,156 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $582,230 | 50,279 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $627,025 | 53,228 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $561,215 | 47,320 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $555,672 | 45,361 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $403,448 | 41,895 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $375,579 | 41,731 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $305,140 | 38,822 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $254,074 | 37,585 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $544,313 | 37,513 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $341,142 | 34,669 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $326,491 | 22,150 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $252,031 | 19,050 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $332,614 | 19,061 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $435,209 | 18,164 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $595,417 | 23,177 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $360,601 | 18,989 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $198,330 | 15,753 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $213,565 | 17,650 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $82,061 | 10,727 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||